malignant neoplasm of the bile duct

Categories:

SOP Numbers	Date of Commencement	Incorporated Material	Status
Reasonable Hypothesis	Date of Commencement	Incorporated Material	Status		Balance of Probabilities
69/2015	70/2015	18/09/2017	Guide to Calculation of Cumulative Equivalent Dose ARPANSA 2 August 2017	Current	Compilation

SOP Numbers		Date of Commencement	Status
Reasonable Hypothesis	Balance of Probabilities	Date of Commencement	Status
58/2017 58/2017	58/2017 58/2017	18/09/2017	Current	Amendment
69/2015 69/2015	70/2015 70/2015	01/06/2015	Current	Principal
49/2011	50/2011	25/05/2011	Revoked	Amendment
21/2007	22/2007	07/03/2007	Revoked	Principal
17/2000	18/2000	19/07/2000	Revoked	Principal
previously known as: cholangiocarcinoma
34/1999	35/1999	12/05/1999	Revoked	Principal
39/1995	40/1995	01/03/1995	Revoked	Principal

Subject	Documents	Relevant SOPs	Date
Explanatory Statements tabled in Houses of Parliament	SoP Explanatory statement 069 of 2015 RH 116 malignant neoplasm of the bile duct 1 June 2015 SoP Explanatory statement 070 of 2015 BoP 116 malignant neoplasm of the bile duct 1 June 2015	69/2015 70/2015	01/06/2015
Amendment Explanatory Statements tabled in Houses of Parliament	Amendment Determination Explanatory Statement No 58 of 2017 Veterans Entitlements SOPs Cumulative Equivalent Dose 18 September 2017	58/2017 58/2017	18/09/2017
Reference List	Reference list - malignant neoplasm of the bile duct - RMA meeting June 2017	58/2017 58/2017	06/06/2017